Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Manon Desgres

1PUBLICATIONS

14CO-AUTHORS

Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Jan 31, 2025

PPARα-mediated lipid metabolism reprogramming supports anti-EGFR therapy resistance in head and neck squamous cell carcinoma.

Valentin Van den Bossche, Julie Vignau, Engy Vigneron

Pageof 1

Frequent Collaborators

1 joint publications

Valentin Van den Bossche

1 joint publications

Engy Vigneron

1 joint publications

Hannah Zaryouh

1 joint publications

Cédric van Marcke

1 joint publications

Lionel Mignion

1 joint publications

Elise Y Lepicard

1 joint publications

Bénédicte F Jordan

1 joint publications

Olivier Lowyck

1 joint publications

Léo Aubert

1 joint publications

Guido T Bommer

Frequent Collaborators

1 joint publications

Valentin Van den Bossche

1 joint publications

Engy Vigneron

1 joint publications

Hannah Zaryouh

1 joint publications

Cédric van Marcke

Top Related Videos

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

See more related videos

Top Related Videos

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

See more related videos